Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.
Christina Lynn RolandBrian K BednarskiKelsey WatsonKeila E TorresJanice N CormierWei-Lien WangAlexander J F LazarNeeta SomaiahKelly K HuntBarry W FeigPublished in: Journal of surgical oncology (2018)
Patients with unifocal disease and radiographic evidence of response to TKI therapy may achieve improved oncologic outcomes when complete surgical resection is achieved following treatment with TKI.
Keyphrases
- rectal cancer
- tyrosine kinase
- squamous cell carcinoma
- advanced non small cell lung cancer
- lymph node
- locally advanced
- stem cells
- adipose tissue
- chronic myeloid leukemia
- robot assisted
- cell therapy
- replacement therapy
- epidermal growth factor receptor
- bone marrow
- insulin resistance
- minimally invasive
- weight loss
- smoking cessation